Skip to main content
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · IEX Real-Time Price · USD
0.248
-0.004 (-1.51%)
At close: Jul 2, 2024, 3:45 PM
0.254
+0.006 (2.34%)
After-hours: Jul 2, 2024, 7:09 PM EDT

InMed Pharmaceuticals Revenue

InMed Pharmaceuticals had revenue of $5.63M in the twelve months ending March 31, 2024, with 140.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.17M with 13.41% year-over-year growth. In the fiscal year ending June 30, 2023, InMed Pharmaceuticals had annual revenue of $4.14M with 279.61% growth.

Revenue (ttm)
$5.63M
Revenue Growth
+140.49%
P/S Ratio
0.37
Revenue / Employee
$432,748
Employees
13
Market Cap
2.07M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20234.14M3.05M279.61%
Jun 30, 20221.09M--
Jun 30, 20210--
Jun 30, 20200--
Jun 30, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
cbdMD 21.58M
SCWorx 3.92M
SciSparc 2.88M
NanoVibronix 2.85M
Tivic Health Systems 1.13M
Aclarion 60.05K
IMAC Holdings -2.09M
Revenue Rankings

INM News

More News